Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
CD3 x CD20 BISPECIFICS
Frontiers | Efficacy and safety of CD19 combined with CD22 or CD20 ...
A, Coexpression of CD19 and CD20 by CD3CD20 cells. CD3/CD19/CD20 triple ...
Circulating CD3 − CD19 + B cells were significantly increased in JORRP ...
CD3 + CD20 + T cells and human diseases. | Download Scientific Diagram
Flow cytometry demonstrating aberrant T cells expressing CD3 and CD19 ...
Therapeutic potential of CD20 x CD3 bispecific antibodies - Omega ...
CD3 low CD20 + cells belong to the B lymphocyte compartment ...
(PDF) Bispecific CD3 × CD19 diabody for T cell-mediated lysis of ...
The ratios of CD3 − CD19 + B cells in PBMC were analyzed by flow ...
CD19 mAb but not CD20 mAb depletes CD19 + CD20 2 autoreactive ASCs in ...
MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule ...
(PDF) Discovery of CD3 + CD19 + cells, a novel lymphocyte subset with a ...
Blinatumomab: a Bispecific CD19-Directed CD3 T-Cell Engager | Value ...
CD19 Research Products
Ki-67 labeling index in CD3, CD19, CD20 and CD138 positive cells in ...
The number of CD3, CD19, CD20 and CD138 positive cells in lamina ...
Flow cytometry showing clonal CD19 and CD20-positive Bcell population ...
Bispecific CAR-T Targeting CD19, CD20 Is ‘Safe and Efficacious’ in ...
Bispecific CD19:CD3 Bridging Chemiluminescence ELISA Kit CD19 82764
Construction and verification of an CD19- CD3 dimert construct for AAV ...
CD19 Expression on normal and malignant B cells (a) Antigen density of ...
CD20 X CD3双特异抗体格局 近日， Genmab 和艾伯维宣布其靶向CD20xCD3的双特异抗体epcoritamab（GEN3013 ...
Sequential antigen loss and branching evolution in lymphoma after CD19 ...
(A) Longitudinal evaluation of total CD3 + T cells, anti-CD19 CAR-T ...
Concepts in immuno-oncology: tackling B cell malignancies with CD19 ...
Design of chimeric antigen receptor (CAR) targeting CD19 and CD20. (A ...
Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric ...
Intein‐based modular chimeric antigen receptor platform for specific ...
Rituximab Cd20
Dual targeting of CD19 and CD22 against B-ALL using a novel high ...
Armstrong生物药资讯 : 全球首款：博锐生物CD3/CD19/CD20三抗获批中国临床-博锐生物 BioRay
Preclinical characterization and comparison between CD3/CD19 bispecific ...
靶点药讯93|博锐生物全球首个CD3/CD19/CD20三抗获批临床、绿叶制药抗肿瘤创新制剂戈舍瑞林微球上市申请获受理 - 知乎
FDA整治药企拖延症，暂缓第四款CD3×CD20双抗上市 - 知乎
Anti-human CD3/CD19 bispecific antibody | InvivoGen
Trispecific antibodies for cancer immunotherapy - Yao - 2023 ...
Phase II trial of co‐administration of CD19‐ and CD20‐targeted chimeric ...
Discovery of CD3+CD19+ cells, a novel lymphocyte subset with a ...
B细胞发育和相关恶性肿瘤期间CD19和CD20抗原的表达模式 - 2024年12月 - 行业研究数据 - 小牛行研
Trispecific antibodies offer a third way forward for anticancer ...
Detection of subsets of CD3+CD20+ T cells in healthy subjects. (A) (i ...
CD20靶点在自身免疫疾病中的研究进展-缔码生物
A CD19/CD3 bispecific antibody for effective immunotherapy of chronic ...
热门靶点组合策略CD3×TAA - 知乎
Identification of CD3-, CD19-, CD14-, CD20-, CD56-, CD127 and CD117 ...
ARI0003: Co-transduced CD19/BCMA dual-targeting CAR-T cells for the ...
全球获批的10款双抗全梳理|CD20|ORR|CD3|双抗|细胞|抗体|靶向|-健康界
Buy Untouched Human Normal Peripheral Blood CD19+ B Cells (Untouched ...
Anti-CD20/CD3 TDB is active in dTG mice. (A) Time course of tissue B ...
Flow cytometry analysis of CD3⁻CD19⁺ B cells and CD3⁻CD20⁺ B cells in ...
国内多抗研发格局 Armstrong 2023年1月19日，赛诺菲注射用SAR443216的临床试验申请获得NMPA受理，用于治疗复发 ...
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naïve/Memory T ...
CD3/CD20 bispecific antibodies deplete B-cells in vivo. Wild-type ...
CD3/CD19/BCMA 从肿瘤免疫到自身免疫性疾病的多面利器 - 知乎
CD3/CD19 Antibody, FITC, PE (22-1903-72)
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen ...
CD3-CD19+CD27-CD43+ B cells are present in peripheral blood. (A) Mean ...
Design of CD19/20/22CAR T-cells a A tricistronic vector was designed ...
全球首个CD3/CD19/CD20三抗产品获批临试！ - 知乎
Identification of dual positive CD19+/CD3+ T cells in a leukapheresis ...
Enumeration of Peripheral Blood CD3-positive T cells and... | Download ...
Frontiers | Advancements in cancer immunotherapies targeting CD20: from ...
Schematic diagrams of chimeric antigen receptor (CAR) structures: (a ...
Anti-CD20/CD3 TDB activates T cells in the presence of target and ...
Immunotherapy of Hematological Malignancies of Human B-Cell Origin with ...
Therapeutic potential of CD20/CD3 bispecific antibodies in the ...
Development of a bicistronic anti-CD19/CD20 CAR construct including ...
一种抗CD3和抗CD19双特异性抗体的制作方法_2
A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL ...
Figure 2 from An optimal antitumor response by a novel CEA/CD3 ...
Percentages of circulating CD3⁻CD19⁺ B cells and CD3⁻CD20⁺ B cells in ...
Anti-CD19/CD20 bispecific antibody with dual Fc domains mediates ...
重磅 8.5亿美金 GSK收购恩沐的CD3/CD19/CD20三抗 - 知乎
The experience with Rituximab in human autoimmune disorders. | Download ...
The CD19–CD21 Complex Regulates Signal Transduction Thresholds ...
CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell ...
CD3亲和力微调：抗肿瘤活性与安全性之间的理想平衡-TCE研发-德泰生物
Treatment of concomitant myasthenia gravis and Lambert-Eaton myasthenic ...
CD20/CD3 Bispecific Antibodies Can Revolutionize B-Cell Lymphoma Therapy
双特异性T细胞衔接器（TCE）-CD3双抗-TCE作用机制/技术平台-德泰生物
Anti-BCMA-Anti-CD19-Anti-CD3-His Trispecific Antibody
Anti-CD19/CD22/CD3 trispecific antibody and application thereof ...
Triple immunohistochemistry for expression of CD3, CD20, and ...
用于用抗CD19/CD20免疫治疗来治疗癌症的组合物和方法与流程_2
40色全光谱流式用于人外周血中主要细胞亚群的深度免疫表型-优宁维
Bispecific Antibody Use in Patients With Lymphoma and Multiple Myeloma ...
Parallel CD19/CD20 CAR-Activated T-Cells Are More Effective for ...
Frontiers | Trispecific eFab-eIg T-cell engagers targeting HER2 and HER3
到底什么是Lin？
Anti-BCMA-Anti-CD19-Anti-CD3 Trispecific Molecule BCMA 100761
T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors ...
Characterization of novel dual tandem CD19/BCMA chimeric antigen ...
CD3/CD19自免双抗研发，这些关键小鼠模型少不了 - 知乎
(A) Baseline CD19/CD20 expression levels per B lymphoblas, and (B ...
Anti-CD20/CD3 T cell–dependent bispecific antibody for the treatment of ...
Development of a compact bidirectional promoter-driven dual chimeric ...
